Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a 52-week, multi-center, randomized, open label, parallel group study to assess the
long term safety and tolerability of once-daily NVA237, using tiotropium as an active
control, in Japanese patients with moderate to severe chronic obstructive pulmonary disease
(COPD) .